Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-, (1S,2S,3R,4R)-

 化学構造式
316173-30-5
CAS番号.
316173-30-5
化学名:
别名:
英語名:
Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-, (1S,2S,3R,4R)-
英語别名:
Peramivir intermediate M11;(1S,2S,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-((tert-butoxycarbonyl)amino)-2-hydroxycyclopentane-1-carboxylic acid;Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-, (1S,2S,3R,4R)-
CBNumber:
CB98100587
化学式:
C19H34N2O6
分子量:
386.48
MOL File:
316173-30-5.mol

Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-, (1S,2S,3R,4R)- 物理性質

安全性情報

Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-, (1S,2S,3R,4R)- 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-, (1S,2S,3R,4R)- 化学特性,用途語,生産方法

Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-, (1S,2S,3R,4R)- 上流と下流の製品情報

原材料

準備製品


Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-, (1S,2S,3R,4R)- 生産企業

Global( 2)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Hangzhou ICH Biofarm Co., Ltd
+86-0571-28186870; +undefined8613073685410
sales@ichemie.com China 985 58
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd 15850510341
shiqingran@wzxchem.com China 3539 58

  • 316173-30-5
  • Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-, (1S,2S,3R,4R)-
  • (1S,2S,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-((tert-butoxycarbonyl)amino)-2-hydroxycyclopentane-1-carboxylic acid
  • Peramivir intermediate M11
Copyright 2017 © ChemicalBook. All rights reserved